CellFiber

CellFiber® is a Tokyo-based startup established in 2015, rooted in proprietorial technology developed at the Institute of Industrial Science, University of Tokyo. Our mission is to make this innovative technology accessible beyond academic circles, driving its widespread adoption of the transformative potential of 3D cell culture using medical grade alginate to revolutionise the way therapeutic cells are produced. In 2020, significant strides were made by applying our technology in cultures of a diverse cell types. Building upon these accomplishments, in 2023, we directed our effort towards developing products and processes that comply with industrial GMP standards and regulatory guidelines, ensuring our commitment to excellence and innovation to improve patient outcomes and medical advancements remains unwavering. We are a plug-and-play bio-manufacturing solution. If you are a CDMO, in therapeutics, pharmaceuticals, or a biotechnology company looking to enhance your scaling processes, talk to us. We are inviting collaborators and beta-testers to work together on your cost reduction in clinical and commercial manufacturing.